複素環化合物 - Takeda GmbH

Title:

複素環化合物

Document Type and Number:

Japanese Patent JP7434249

Kind Code:

B2

Abstract:

Provided is a compound that can have an effect of inhibiting MALT1 and is expected as useful as a prophylactic or therapeutic drug for cancer, etc. A compound represented by formula (I) [wherein each symbol is as defined in the description], a salt thereof, or a cocrystal, a hydrate or a solvate of the same.

More Like This:

WO/2014/056771	NEW PYRROLIDINE DERIVATIVES AND THEIR USE AS ACETYL-COA CARBOXYLASE INHIBITORS
JP7301222	Substituted tricyclic compounds as PRMT5 inhibitors and their applications
JP2005515961	Melanin Aggregate Hormone Receptor Ligand: Substituted 1-Benzyl-4-arylpiperazin Analog

Inventors:

Koji Hirayama
Yoshiteru Ito
Hiroshi Sakano
Hidekazu Tokuhara
Toshio Tanaka
Yasuyoshi Arikawa
Noriyuki Arai
Yoichi Kawakita
Shinichi Imamura

Application Number:

JP2021179627A

Publication Date:

February 20, 2024

Filing Date:

November 02, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Takeda GmbH

International Classes:

C07D471/04; A61K31/444; A61K31/5025; A61P35/00; A61P43/00; C07D487/04

Domestic Patent References:

JP6972384B2
JP2016539975A

Foreign References:

WO2017081641A1
WO2015181747A1
WO2018165385A1
WO2018085247A1
WO2018020474A1
WO1999015526A1

Attorney, Agent or Firm:

Hajime Takashima
Mitsuyoshi Kamada
Kyoko Doi
Yaeko Tamura
Hirofumi Taima
Atsuko Akai
Tomiya Tosaki
Eiji Tabuse

Previous Patent: Sugar targeting therapeutic agent

Next Patent: Humanized antigen-binding domain for CD19 and methods of use